AKEJF yields 3.12% · PFE yields 6.13%● Live data
📍 AKEJF pulled ahead of the other in Year 1
Combined, AKEJF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AKEJF + PFE for your $10,000?
ARIAKE JAPAN Co., Ltd. manufactures, processes, and sells natural seasoning products from chicken, pork, and beef. The company also engages in the production, processing, export/import, and sale of agricultural and livestock products, marine products, quasi-drugs, and non-pharmaceutical products, as well as the management of restaurants. It provides chicken bone base soups, ramen soups, chanpon soups, bouillon and consomme products, sauce bases, and Japanese bouillon products; and livestock meat, including beef, pork, and chicken, as well as shrimps, garlic, and seasoning oils. The company offers its products to instant noodle manufacturing, food service, and food processing industries. It operates in Japan, the United States, China, Taiwan, France, Belgium, the Netherlands, and Indonesia. The company was formerly known as Ariake Tokushu Suisan Hanbai Co., Ltd. and changed its name to ARIAKE JAPAN Co., Ltd. in April 1990. ARIAKE JAPAN Co., Ltd. was founded in 1966 and is headquartered in Tokyo, Japan.
Full AKEJF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.